SlideShare a Scribd company logo
Challenges in HIV prevention
Presented BY:- Tashfeen Ahmad
ADAM UNIVERSITY SCHOOL OF MEDICINE
8th semester
Content
• Introduction
• Context body
• Conclusion
• References
Introduction
 June 1981 first Case of AIDS.
 past 40 years, 77.3 million HIV
infections
 40.1 million [33.6–48.6 million]
Deaths
 In 2017:-
 < 1 million died of AIDS-related
causes
 about 1.8 million acquired.
 In 2020 :-
 estimated 1.5 million (UI 1.0 to 2.0
million) people acquired HIV
 people living with HIV globally to
37.7 million (UI 30.2 to 45.1 million
Currently, for every two people who
go on treatment for HIV and AIDS,
five People become infected.
Incubation Period
• The interval from HIV infection to the
diagnosis of AIDS ranges from about 9 months
to 20 years or longer, with a median of 12
years.
Failure to implement the strategy
Diagnosis:- 87% in
the Netherlands to 11% in
Yemen
Treatment coverage:- ranged
from 71% in Switzerland to 3%
in Afghanistan
Viral suppression:- 68% in
Switzerland and 7% in China.
Awareness of getting infection
• Nearly one in eight
(approx. 4.8 million people) do
not know they are infected.
Because many new infections
are transmitted by people who
do not know they are infected,
undiagnosed infection remains
a significant factor fueling the
HIV epidemic.
Fear for Testing
• fear and misperceptions can still
keep people from finding out
their HIV status:
• Many people do not believe they
are at risk for HIV infection.
• misunderstand the testing
process,
• concerned that other people will
find out that they sought testing
at all
• avoid testing simply because they
are afraid their test will be
positive.
• Misconception of getting HIV at
diagnostic center
Not Receiving Ongoing Treatment
• treatment coverage ranged
from 71% in Switzerland to
3% in Afghanistan.
• Expensive treatment,
• Lack of social support
• personal capacity to
adhere,
• depression,
• disruptions in daily routine,
• substance use,
• Due to insufficient supply
of antiretroviral therapy or
ART
High community rates of HIV
• African Americans and Latinos are at increased
risk of being exposed to HIV infection with each
sexual encounter.
• MSM
• Bisexual male
• More than one sexual partner
• Unprotected sex
• Sex workers
• IV Drug abusers
• Reuse of needles
Low socioeconomic status
• food insufficiency
• Unaffordable ART
• Unsafe sex
• unable to access HIV services
Limited Resources for HIV Prevention
• Inadequate funds
• Less volunteers for spreading awareness
• Lack of importance from govt. in many countries
• Lack of diagnostic kits
• Insufficient AIDS center
• Insufficient production of contraceptive items
• Lack of injecting materials
• High prices of treatment
Complacent about HIV
• U.S. President Donald
Trump's proposed
reduction in investment
in groundbreaking
organizations fighting
AIDS such as PEPFAR,
• Trump also reportedly
closed down the White
House's Office of National
AIDS Policy in January
2017
• Many don’t consider AIDS
as a disease
HIV in Pregnancy & Children
Conclusion
• First and foremost is failure to implement of the
strategy so we need to focus on the new
methods to achieve goals.
• Govt. should consider HIV/AIDS a major
problem.
• Spread awareness so more and more people get
to know about HIV/AIDS and its complications.
• Then we need to raise funds for HIV/AIDS
programs and centers to control spread and treat
infected.
• Scaling up production of preventive tools.
References
• Barriers and facilitators of access to HIV prevention, care, and treatment services among people living with HIV in Kerman,
Iran: a qualitative study Zahra Jaafari1, Willi McFarland2, Sana Eybpoosh3, Seyed Vahid Ahmadi Tabatabaei4, Mehdi Shafiei
Bafti5, Ebrahim Ranjbar6 and Hamid Sharifi1*
• World health statistics 2020: monitoring health for the SDGs, sustainable development goals. Geneva: World Health
Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
• World health statistics 2022: monitoring health for the SDGs, sustainable development goals. Geneva: World Health
Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
• World health statistics 2019: monitoring health for the SDGs, sustainable development goals. Geneva: World Health
Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.
• n Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-
2030. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
• Lucie Seyler, BMBCh, DTM&H,Department of Internal Medicine andInfectious Diseases, HIV ReferenceCenter, UZ Brussel,
Laarbeeklaan 101,1090 Brussels, Belgium,phone: +32 2 477 6001,email: lucie.seyler@uzbrussel.beReceived: October 15,
2018.Accepted: October 16, 2018.Published online: October 31, 2018.Conflict of interest: LS, PL, andSDA have participated
in advisoryboards for Gilead, Janssens, MSD,and ViiV Healthcare.Pol Arch Intern Med. 2018;128 (10): 609-
616doi:10.20452/pamw.4357Copyright by Medycyna Praktyczna,Kraków 2018
• Jaafari et al. BMC Health Services Research (2022) 22:1097 https://doi.org/10.1186/s12913-022-08483-4
• Prof Michael H Merson,Duke Global Health Institute,Box 90519, Duke University,Durham, NC 27708, USA
• https://doi.org/10.1016/j.cct.2021.106402
• https://www.hsph.harvard.edu/news/features/progress-challenges-in-tackling-pediatric-hivaids/
QUESTIONS?

More Related Content

Similar to Challenges in HIV prevention Tashfeen Ahmad.pptx

Std-2021.pptx
Std-2021.pptxStd-2021.pptx
Std-2021.pptx
sergeipee
 
Aids present
Aids presentAids present
Aids present
David Stephens
 
WORLD AIDS DAY 2015 ,Where we went wrong
WORLD AIDS DAY 2015 ,Where we went wrongWORLD AIDS DAY 2015 ,Where we went wrong
WORLD AIDS DAY 2015 ,Where we went wrong
CONSULTANT IN OBGYN, ODISHA ,INDIA
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
HopkinsCFAR
 
What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVWhat Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
European Centre for Disease Prevention and Control
 
AIDS CONTROL PROGRAMME
AIDS CONTROL PROGRAMMEAIDS CONTROL PROGRAMME
AIDS CONTROL PROGRAMME
MAHESWARI JAIKUMAR
 
Gender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girlsGender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girls
Sumaiya Akter Snigdha
 
AIDS CONTROL
AIDS CONTROLAIDS CONTROL
AIDS CONTROL
KULDEEP VYAS
 
AidsNACP 2.pptx 4th year community health aids notes
AidsNACP 2.pptx 4th year community health aids notesAidsNACP 2.pptx 4th year community health aids notes
AidsNACP 2.pptx 4th year community health aids notes
BincyBinu6
 
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptxNATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
KritikaDhawan9
 
Epidemiology of HIV/AIDS
Epidemiology of HIV/AIDSEpidemiology of HIV/AIDS
Epidemiology of HIV/AIDS
Niru Magar
 
BASIC Concept Of HIV/AIDS
BASIC Concept Of HIV/AIDSBASIC Concept Of HIV/AIDS
BASIC Concept Of HIV/AIDS
Md Jahirul Islam Sojib
 
HIV History & Epidemiology by Dr Karl Henson
HIV History & Epidemiology by Dr Karl HensonHIV History & Epidemiology by Dr Karl Henson
HIV History & Epidemiology by Dr Karl Henson
Katerina Leyritana
 
2 hiv a communicable disease
2 hiv  a communicable disease2 hiv  a communicable disease
2 hiv a communicable disease
Mahendra Poudel
 
AIDS - HIV
AIDS - HIVAIDS - HIV
AIDS - HIV
Axiom Sparz
 
AIDS and Global health diplomacy.pptx
AIDS and Global health diplomacy.pptxAIDS and Global health diplomacy.pptx
AIDS and Global health diplomacy.pptx
SujitKumarBehera16
 
HIV Update 2017
HIV Update  2017 HIV Update  2017
HIV Update 2017
Tahseen Siddiqui
 

Similar to Challenges in HIV prevention Tashfeen Ahmad.pptx (20)

Std-2021.pptx
Std-2021.pptxStd-2021.pptx
Std-2021.pptx
 
Aids present
Aids presentAids present
Aids present
 
WORLD AIDS DAY 2015 ,Where we went wrong
WORLD AIDS DAY 2015 ,Where we went wrongWORLD AIDS DAY 2015 ,Where we went wrong
WORLD AIDS DAY 2015 ,Where we went wrong
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
 
What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVWhat Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
 
AIDS
AIDSAIDS
AIDS
 
AIDS CONTROL PROGRAMME
AIDS CONTROL PROGRAMMEAIDS CONTROL PROGRAMME
AIDS CONTROL PROGRAMME
 
Gender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girlsGender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girls
 
World aids day
World aids dayWorld aids day
World aids day
 
HIV/AIDS in sudan
HIV/AIDS in sudanHIV/AIDS in sudan
HIV/AIDS in sudan
 
AIDS CONTROL
AIDS CONTROLAIDS CONTROL
AIDS CONTROL
 
AidsNACP 2.pptx 4th year community health aids notes
AidsNACP 2.pptx 4th year community health aids notesAidsNACP 2.pptx 4th year community health aids notes
AidsNACP 2.pptx 4th year community health aids notes
 
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptxNATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
 
Epidemiology of HIV/AIDS
Epidemiology of HIV/AIDSEpidemiology of HIV/AIDS
Epidemiology of HIV/AIDS
 
BASIC Concept Of HIV/AIDS
BASIC Concept Of HIV/AIDSBASIC Concept Of HIV/AIDS
BASIC Concept Of HIV/AIDS
 
HIV History & Epidemiology by Dr Karl Henson
HIV History & Epidemiology by Dr Karl HensonHIV History & Epidemiology by Dr Karl Henson
HIV History & Epidemiology by Dr Karl Henson
 
2 hiv a communicable disease
2 hiv  a communicable disease2 hiv  a communicable disease
2 hiv a communicable disease
 
AIDS - HIV
AIDS - HIVAIDS - HIV
AIDS - HIV
 
AIDS and Global health diplomacy.pptx
AIDS and Global health diplomacy.pptxAIDS and Global health diplomacy.pptx
AIDS and Global health diplomacy.pptx
 
HIV Update 2017
HIV Update  2017 HIV Update  2017
HIV Update 2017
 

More from Tashfeen Ahmad

pericardium.pptx
pericardium.pptxpericardium.pptx
pericardium.pptx
Tashfeen Ahmad
 
Cognitive dissonance
Cognitive dissonanceCognitive dissonance
Cognitive dissonance
Tashfeen Ahmad
 
Mitosis , Cell division
Mitosis , Cell divisionMitosis , Cell division
Mitosis , Cell division
Tashfeen Ahmad
 
Medication administration.ppt
Medication administration.pptMedication administration.ppt
Medication administration.ppt
Tashfeen Ahmad
 
Nanopore sequencing .
Nanopore sequencing .Nanopore sequencing .
Nanopore sequencing .
Tashfeen Ahmad
 
Nanopore Sequencing
Nanopore SequencingNanopore Sequencing
Nanopore Sequencing
Tashfeen Ahmad
 
Yellow fever
Yellow feverYellow fever
Yellow fever
Tashfeen Ahmad
 
Glycolysis biochemistry
Glycolysis biochemistryGlycolysis biochemistry
Glycolysis biochemistry
Tashfeen Ahmad
 

More from Tashfeen Ahmad (8)

pericardium.pptx
pericardium.pptxpericardium.pptx
pericardium.pptx
 
Cognitive dissonance
Cognitive dissonanceCognitive dissonance
Cognitive dissonance
 
Mitosis , Cell division
Mitosis , Cell divisionMitosis , Cell division
Mitosis , Cell division
 
Medication administration.ppt
Medication administration.pptMedication administration.ppt
Medication administration.ppt
 
Nanopore sequencing .
Nanopore sequencing .Nanopore sequencing .
Nanopore sequencing .
 
Nanopore Sequencing
Nanopore SequencingNanopore Sequencing
Nanopore Sequencing
 
Yellow fever
Yellow feverYellow fever
Yellow fever
 
Glycolysis biochemistry
Glycolysis biochemistryGlycolysis biochemistry
Glycolysis biochemistry
 

Recently uploaded

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 

Recently uploaded (20)

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 

Challenges in HIV prevention Tashfeen Ahmad.pptx

  • 1. Challenges in HIV prevention Presented BY:- Tashfeen Ahmad ADAM UNIVERSITY SCHOOL OF MEDICINE 8th semester
  • 2. Content • Introduction • Context body • Conclusion • References
  • 3. Introduction  June 1981 first Case of AIDS.  past 40 years, 77.3 million HIV infections  40.1 million [33.6–48.6 million] Deaths  In 2017:-  < 1 million died of AIDS-related causes  about 1.8 million acquired.  In 2020 :-  estimated 1.5 million (UI 1.0 to 2.0 million) people acquired HIV  people living with HIV globally to 37.7 million (UI 30.2 to 45.1 million Currently, for every two people who go on treatment for HIV and AIDS, five People become infected.
  • 4.
  • 5. Incubation Period • The interval from HIV infection to the diagnosis of AIDS ranges from about 9 months to 20 years or longer, with a median of 12 years.
  • 6. Failure to implement the strategy Diagnosis:- 87% in the Netherlands to 11% in Yemen Treatment coverage:- ranged from 71% in Switzerland to 3% in Afghanistan Viral suppression:- 68% in Switzerland and 7% in China.
  • 7. Awareness of getting infection • Nearly one in eight (approx. 4.8 million people) do not know they are infected. Because many new infections are transmitted by people who do not know they are infected, undiagnosed infection remains a significant factor fueling the HIV epidemic.
  • 8. Fear for Testing • fear and misperceptions can still keep people from finding out their HIV status: • Many people do not believe they are at risk for HIV infection. • misunderstand the testing process, • concerned that other people will find out that they sought testing at all • avoid testing simply because they are afraid their test will be positive. • Misconception of getting HIV at diagnostic center
  • 9. Not Receiving Ongoing Treatment • treatment coverage ranged from 71% in Switzerland to 3% in Afghanistan. • Expensive treatment, • Lack of social support • personal capacity to adhere, • depression, • disruptions in daily routine, • substance use, • Due to insufficient supply of antiretroviral therapy or ART
  • 10. High community rates of HIV • African Americans and Latinos are at increased risk of being exposed to HIV infection with each sexual encounter. • MSM • Bisexual male • More than one sexual partner • Unprotected sex • Sex workers • IV Drug abusers • Reuse of needles
  • 11. Low socioeconomic status • food insufficiency • Unaffordable ART • Unsafe sex • unable to access HIV services
  • 12. Limited Resources for HIV Prevention • Inadequate funds • Less volunteers for spreading awareness • Lack of importance from govt. in many countries • Lack of diagnostic kits • Insufficient AIDS center • Insufficient production of contraceptive items • Lack of injecting materials • High prices of treatment
  • 13. Complacent about HIV • U.S. President Donald Trump's proposed reduction in investment in groundbreaking organizations fighting AIDS such as PEPFAR, • Trump also reportedly closed down the White House's Office of National AIDS Policy in January 2017 • Many don’t consider AIDS as a disease
  • 14. HIV in Pregnancy & Children
  • 15. Conclusion • First and foremost is failure to implement of the strategy so we need to focus on the new methods to achieve goals. • Govt. should consider HIV/AIDS a major problem. • Spread awareness so more and more people get to know about HIV/AIDS and its complications. • Then we need to raise funds for HIV/AIDS programs and centers to control spread and treat infected. • Scaling up production of preventive tools.
  • 16. References • Barriers and facilitators of access to HIV prevention, care, and treatment services among people living with HIV in Kerman, Iran: a qualitative study Zahra Jaafari1, Willi McFarland2, Sana Eybpoosh3, Seyed Vahid Ahmadi Tabatabaei4, Mehdi Shafiei Bafti5, Ebrahim Ranjbar6 and Hamid Sharifi1* • World health statistics 2020: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO. • World health statistics 2022: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO. • World health statistics 2019: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. • n Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022- 2030. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO. • Lucie Seyler, BMBCh, DTM&H,Department of Internal Medicine andInfectious Diseases, HIV ReferenceCenter, UZ Brussel, Laarbeeklaan 101,1090 Brussels, Belgium,phone: +32 2 477 6001,email: lucie.seyler@uzbrussel.beReceived: October 15, 2018.Accepted: October 16, 2018.Published online: October 31, 2018.Conflict of interest: LS, PL, andSDA have participated in advisoryboards for Gilead, Janssens, MSD,and ViiV Healthcare.Pol Arch Intern Med. 2018;128 (10): 609- 616doi:10.20452/pamw.4357Copyright by Medycyna Praktyczna,Kraków 2018 • Jaafari et al. BMC Health Services Research (2022) 22:1097 https://doi.org/10.1186/s12913-022-08483-4 • Prof Michael H Merson,Duke Global Health Institute,Box 90519, Duke University,Durham, NC 27708, USA • https://doi.org/10.1016/j.cct.2021.106402 • https://www.hsph.harvard.edu/news/features/progress-challenges-in-tackling-pediatric-hivaids/
  • 17.